Physician profile
Michael K Kim
NPI 1437198678
$5,956.09
in general payments reported to CMS, 2019-2025
35 companies · $1,143 in 2025
The $1,143 reported for 2025 was more than what 88% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $885 · 2020: $960 · 2021: $889 · 2022: $888 · 2023: $784 · 2024: $407 · 2025: $1,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,333.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,610.03 | 2019-2025 | Xpress Ent Dilation System, Xpress Loprofile, Clarifix Cryotherapy Device |
| Regeneron Healthcare Solutions, INC. | $442.67 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $365.03 | 2021-2025 | Nucala |
| Optinose US, INC. | $358.92 | 2020-2025 | |
| Incyte Corporation | $308.63 | 2021-2025 | Opzelura, Opzelura |
| Genzyme Corporation | $280.34 | 2020-2024 | |
| Aerin Medical INC. | $278.20 | 2019-2025 | |
| Acclarent, INC | $255.12 | 2019-2021 | |
| Medtronic, INC. | $227.12 | 2021-2022 | |
| Lilly USA, LLC | $216.21 | 2019-2025 | Taltz, Ebglyss, Zepbound |
| Medtronic USA, INC. | $208.65 | 2020 | |
| Janssen Biotech, INC. | $171.32 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Amgen INC. | $144.56 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $142.72 | 2020-2025 | Blu-U, Odomzo |
| Intersect Ent, INC. | $131.20 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xoran Technologies LLC | $108.35 | 2019-2020 | |
| Leo Pharma INC. | $107.84 | 2019-2025 | Adbry |
| Integra Lifesciences Corporation | $91.19 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Smith+Nephew, INC. | $71.61 | 2022-2025 | Tula |
| Galderma Laboratories, L.P. | $46.96 | 2019-2022 | |
| Medical Device Business Services, INC. | $44.78 | 2022 | |
| Organogenesis INC. | $40.94 | 2025 | Apligraf |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $37.00 | 2020 | |
| Abbvie INC. | $36.59 | 2019-2021 | |
| Biolase, INC. | $30.18 | 2019 | |
| Dusa Pharmaceuticals, INC. | $26.66 | 2019 | |
| Itamar Medical INC | $22.05 | 2022 | |
| Mayne Pharma Commercial LLC | $22.05 | 2019 | |
| Misonix INC | $21.11 | 2021 | |
| Neurent Medical Limited | $21.04 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Inspire Medical Systems, INC. | $19.98 | 2023 | Inspire |
| Astrazeneca Pharmaceuticals LP | $19.79 | 2025 | Tezspire |
| Hikma Pharmaceuticals USA | $19.75 | 2023 | Ryaltris |
| Cipher Pharmaceuticals US LLC | $15.93 | 2025 | Natroba, Spinosad |
| Aclaris Therapeutics, INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.